Telescope Innovations to Deliver First Self-Driving Lab for Korea's Largest Biopharma Manufacturers Association
HIGHLIGHTS This installation for Korea's largest biopharma association represents the first Self-Driving Lab ("SDL") for drug development to be deployed in Korea Partnership supports Korea's transition toward automated and digital R&D SDL automates continuous experimental optimization using robotics, analytics, and AI SDLs show expanding commercial relevance across pharma, minerals, energy, agriculture, and chemical
Technology, Chemical, Pharmaceuticals
2025-11-17 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Conditionally Approved for up to $3.36 M in Government Funding to Advance Lithium Processing Technology
Vancouver, British Columbia--(Newsfile Corp. - November 4, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leader in providing intelligent automation platforms and services that accelerate chemical process development. The Company is pleased to announce that two Government of Canada funding streams totalling up to CAD $3.36 M have been formally or conditionally awarded to Telescope to support th
Technology, Chemical, Pharmaceuticals
2025-11-04 11:00 AM EST | Telescope Innovations Corp.
Anne-Kathrin Stoller to Become New CEO at Bachem
Bubendorf, Switzerland--(Newsfile Corp. - October 31, 2025) - Ad hoc announcement pursuant to Art. 53 LR Anne-Kathrin Stoller to become new CEO at Bachem Bachem (SIX: BANB) announced today that its Board of Directors has appointed Anne-Kathrin Stoller, currently Head of Bachem Americas and previously the company's long-standing Chief Marketing Officer (CMO), as its new CEO, effective January 1, 2026. She succeeds Thomas Meier, wh
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-10-31 2:23 AM EDT | Bachem Holding AG